Filing Details

Accession Number:
0001190725-18-000022
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-27 17:44:55
Reporting Period:
2018-04-26
Accepted Time:
2018-04-27 17:44:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 522154066
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638479 M. Thomas Burns C/O Xoma Corporation
2200 Powell Street, Suite 310
Emeryville CA 94608
Svp, Finance & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2018-04-26 8,345 $5.50 14,900 No 4 M Direct
Common Shares Disposition 2018-04-26 8,345 $24.69 6,555 No 4 S Direct
Common Shares Acquisiton 2018-04-27 2,655 $5.50 9,210 No 4 M Direct
Common Shares Disposition 2018-04-27 2,655 $24.77 6,555 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Non-Qualified Share Option (right to buy) Disposition 2018-04-26 8,345 $0.00 8,345 $5.50
Common Shares Non-Qualified Share Option (right to buy) Disposition 2018-04-27 2,655 $0.00 2,655 $5.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,655 2017-12-21 2026-12-22 No 4 M Direct
24,000 2017-12-21 2026-12-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 2,390 Indirect by 401(k)
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.50 to $25.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.75 to $24.835, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.